This federal contract award to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, is a $39,774.12 firm fixed-price delivery order placed against the General Services Administration (GSA) Pharmaceuticals and Drugs schedule (FSS-61-IB). The award is for the provision of Oxervate (cenegermin-bkbj) 0.002% ophthalmic solution, a medication used to treat neurotrophic keratitis. The ordering agency is the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA), which places these orders to fulfill urgent medication needs at VA facilities. Dompe U.S. Inc. also holds a $2.4 million blanket purchase agreement with the VA National Acquisition Center specifically for Oxervate products, as well as a $5 million FSS schedule contract to provide pharmaceuticals. This award does not have a set-aside designation.
Generated 3/6/25, 10:00 AM